| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | -36.6% |
| SG&A Expense | $4.8M | -23.0% |
| Operating Income | -$8.3M | +29.5% |
| Net Income | -$8.2M | +30.1% |
| EPS (Basic) | -$0.32 | -168.1% |
| EPS (Diluted) | -$0.32 | -168.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.1M | -72.5% |
| Current Assets | $3.5M | -69.9% |
| Total Assets | $4.1M | -65.1% |
| Total Liabilities | $261K | -75.6% |
| Stockholders' Equity | $3.8M | -64.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | +16.4% |
| Financing Cash Flow | -$62K | -101.0% |